FARABEGOLI, FULVIA

FARABEGOLI, FULVIA  

FABIT - DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE  

FARABEGOLI F.; F .FARABEGOLI; FARABEGOLI FU  

Mostra records
Risultati 1 - 20 di 35 (tempo di esecuzione: 0.037 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity Masi, Mirco; Poppi, Laura; Previtali, Viola; Nelson, Shannon R; Wynne, Kieran; Varignani, Giulia;... espandi Falchi, Federico; Veronesi, Marina; Albanesi, Ennio; Tedesco, Daniele; De Franco, Francesca; Ciamarone, Andrea; Myers, Samuel H; Ortega, Jose Antonio; Bagnolini, Greta; Ferrandi, Giovanni; Farabegoli, Fulvia; Tirelli, Nicola; Di Stefano, Giuseppina; Oliviero, Giorgio; Walsh, Naomi; Roberti, Marinella; Girotto, Stefania; Cavalli, Andrea 2025-01-01 CELL DEATH DISCOVERY - 1.01 Articolo in rivista Masi_et_al-2025-Cell_Death_Discovery.pdf41420_2025_2382_MOESM3_ESM.xlsx41420_2025_2382_MOESM2_ESM.pdf41420_2025_2382_MOESM1_ESM.docx
Differential enantiomers activity of ARN24089 to achieve synthetic lethality in pancreatic cancer Previtali, Viola; Masi, Mirco; Poppi, Laura; Varignani, Giulia; Falchi, Federico; Tedesco, Daniel... espandie; Wynne, Kieran; Oliviero, Giorgio; Bagnolini, Greta; Farabegoli, Fulvia; DI STEFANO, Giuseppina; Girotto, Stefania; Roberti, Marinella; Cavalli, Andrea 2024-01-01 - - 4.03 Poster -
A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer Laura Poppi, Samuel H Myers, Viola Previtali, Francesco Rinaldi, Fulvia Farabegoli, Giuseppina Di... espandi Stefano, Naomi Walsh, Marinella Roberti, Andrea Cavalli 2023-01-01 - FEBS PRESS 4.03 Poster -
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer Myers, S. H.; Poppi, L.; Rinaldi, F.; Veronesi, M.; Ciamarone, A.; Previtali, V.; Bagnolini, G.; ... espandiSchipani, F.; Ortega Martínez, J. A.; Girotto, S.; Di Stefano, G.; Farabegoli, F.; Walsh, N.; De Franco, F.; Roberti, M.; Cavalli, A. 2023-01-01 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - 1.01 Articolo in rivista 1-s2.0-S0223523423010814-mmc1.docx1-s2.0-S0223523423010814-main.pdf
Large Population Of Homogeneous Spheroids Models For Testing Toxicity And Diffusion Of Nanomaterials Emanuela Mensà, Ottavia Tartagni, Fulvia Farabegoli, Renato Brandimarti, Dario De Biase, Giampaol... espandio Zuccheri 2023-01-01 - - 4.02 Riassunto (Abstract) -
Proteomic profile of BxPC-3 cells after treatment with BRC4 Viola Previtali, Samuel H. Myers, Laura Poppi, Kieran Wynne, Irene Casamassima Stefania Girotto, ... espandiGiuseppina Di Stefano, Fulvia Farabegoli, Marinella Roberti, Giorgio Oliviero, Andrea Cavalli 2023-01-01 JOURNAL OF PROTEOMICS - 1.01 Articolo in rivista -
Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement Carmen Ciavarella, Ilenia Motta, Santino Blando, Sabrina Valente, Fulvia Farabegoli, Maria Letizi... espandia Focarete, Mauro Gargiulo, Gianandrea Pasquinelli 2022-01-01 BIOMEDICINES - 1.01 Articolo in rivista biomedicines-10-01276-v2.pdf
Epigallocatechin-3-gallate Delivered in Nanoparticles Increases Cytotoxicity in Three Breast Carcinoma Cell Lines Farabegoli F.; Granja A.; Magalhaes J.; Purgato S.; Voltattorni M.; Pinheiro M. 2022-01-01 ACS OMEGA - 1.01 Articolo in rivista acsomega.2c01829(2022).pdf
Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy Farabegoli, Fulvia; Pinheiro, Marina 2022-01-01 FRONTIERS IN PHARMACOLOGY - 1.01 Articolo in rivista fphar-13-809706.pdf
Lactate is a potential promoter of tamoxifen resistance in MCF7 cells Rossi V.; Govoni M.; Farabegoli F.; Di Stefano G. 2022-01-01 BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS - 1.01 Articolo in rivista Revised Manuscript.pdf
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination Schipani, Fabrizio; Manerba, Marcella; Marotta, Roberto; Poppi, Laura; Gennari, Arianna; Rinaldi,... espandi Francesco; Armirotti, Andrea; Farabegoli, Fulvia; Roberti, Marinella; Di Stefano, Giuseppina; Rocchia, Walter; Girotto, Stefania; Tirelli, Nicola; Cavalli, Andrea 2022-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-23-08338-v3 (1).pdf
Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC) Petrocelli, Giovannamaria; Farabegoli, Fulvia; Valerii, Maria Chiara; Giovannini, Catia; Sardo, A... espandilberto; Spisni, Enzo 2021-01-01 MOLECULES - 1.01 Articolo in rivista molecules-26-00885.pdf
EGCG mediated targeting of deregulated signaling pathways and non-coding rnas in different cancers: Focus on JAK/STAT, Wnt/β-catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL mediated signaling pathways Farooqi A.A.; Pinheiro M.; Granja A.; Farabegoli F.; Reis S.; Attar R.; Sabitaliyevich U.Y.; Xu B... espandi.; Ahmad A. 2020-01-01 CANCERS - 1.01 Articolo in rivista cancers-12-00951.pdf
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib Bagnolini G.; Milano D.; Manerba M.; Schipani F.; Ortega J.A.; Gioia D.; Falchi F.; Balboni A.; F... espandiarabegoli F.; De Franco F.; Robertson J.; Pellicciari R.; Pallavicini I.; Peri S.; Minucci S.; Girotto S.; Di Stefano G.; Roberti M.; Cavalli A. 2020-01-01 JOURNAL OF MEDICINAL CHEMISTRY - 1.01 Articolo in rivista ASAP_acs.jmedchem.9b01526.pdf
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy Bagnolini, Greta; Balboni, Andrea; Manerba, Marcella; Farabegoli, Fulvia; DI STEFANO, Giuseppina;... espandi Roberti, Marinella; Cavalli, Andrea 2019-01-01 - - 4.03 Poster -
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells Roberti, Marinella; Schipani, Fabrizio; Bagnolini, Greta; Milano, Domenico; Giacomini, Elisa; Fal... espandichi, Federico; Balboni, Andrea; Manerba, Marcella; Farabegoli, Fulvia; Francesca De Franco, ; Robertson, Janet; Minucci, Saverio; Pallavicini, Isabella; DI STEFANO, Giuseppina; Girotto, Stefania; Pellicciari, Roberto; and Andrea Cavalli, ; Cavalli, Andrea 2019-01-01 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - 1.01 Articolo in rivista -
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in cancer treatment Bagnolini, Greta; Balboni, Andrea; Farabegoli, Fulvia; DI STEFANO, Giuseppina; Roberti, Marinella... espandi; Cavalli, Andrea 2018-01-01 - - 4.01 Contributo in Atti di convegno -
Epigallocatechin-3-gallate and 6-OH-11-O-hydroxyphenanthrene limit BE(2)-C neuroblastoma cell growth and neurosphere formation in vitro Farabegoli, Fulvia*; Govoni, Marzia; Spisni, Enzo; Papi, Alessio 2018-01-01 NUTRIENTS - 1.01 Articolo in rivista nutrients-10-01141.pdf
Betalains increase vitexin-2-O-xyloside cytotoxicity in CaCo-2 cancer cells Farabegoli, F.; Scarpa, E.S.; Frati, A.; Serafini, G.; Papi, A.; Spisni, E.; Antonini, E.; Benede... espanditti, S.; Ninfali, P 2017-01-01 FOOD CHEMISTRY - 1.01 Articolo in rivista Farabegoli2017Copertina_GENERICA_UNIBO_postprint_IRIS-1.pdf
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy Bagnolini, Greta; Falchi, F.; Farabegoli, F.; Di Stefano, G.; Roberti, M.; Cavalli, A. 2017-01-01 - - 4.01 Contributo in Atti di convegno -